Retrospective evaluation reveals retrieval-augmented generation enhances glaucoma decision-making accuracy, suggesting significant potential for clinical tools.
Background Large language models (LLMs) demonstrate strong performance in knowledge-based medical tasks, yet their clinical reasoning capabilities in complex ophthalmic decision-making, particularly glaucoma management, remain insufficiently characterized. Retrieval-augmented generation (RAG) has been proposed as a strategy to improve factual grounding and safety, but its clinical value requires systematic evaluation. Methods We conducted a retrospective, scenario-based comparative evaluation using 40 real-world glaucoma cases spanning primary, secondary, postoperative, and end-stage disease. Six model conditions (GPT, Gemini, and Grok, each with and without RAG) were assessed using a guideline-grounded framework covering medical accuracy, key point coverage, logical completeness, and a separate qualitative safety audit. Model outputs were compared with written responses from four practicing ophthalmologists. All responses were independently scored by two masked glaucoma specialists using a prespecified ordinal rubric, and formal inter-rater reliability and paired sensitivity analyses were performed. Results RAG-enhanced models consistently outperformed their matched non-RAG counterparts across evaluation domains. In human-rating sensitivity analyses, the composite RAG advantage remained significant for GPT (mean difference 0.119, 95% CI 0.068 to 0.173), Gemini (0.095, 0.030 to 0.161), and Grok (0.110, 0.033 to 0.194). Inter-rater agreement of the ordinal rubric was limited, supporting consensus adjudication and cautious interpretation of AI-human comparisons. Conclusions Retrieval augmentation was associated with more accurate, more complete, and more safety-aware glaucoma reasoning under this scenario-based evaluation. These findings support the potential value of RAG-enhanced LLMs as supervised clinical decision-support tools, but they do not establish standalone clinical use. Safety was evaluated as a separate audit layer rather than as part of the weighted composite score.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: